Form 4: Intuitive Surgical CEO Gary Guthart Executes Stock Option, Sells Shares, and Donates to Charity

Intuitive Surgical CEO Gary Guthart exercised stock options, sold shares under a 10b5-1 trading plan, and donated shares to a Donor Advised Fund.

Summary

• On July 30, 2024, Gary Guthart, CEO of Intuitive Surgical Inc., executed a non-qualified stock option to acquire 25,200 shares at a price of $57.1111 per share.
• Guthart sold 23,388 shares of common stock at a weighted average price of $443.0698, with individual sales ranging from $437.94 to $447.76.
• He also donated 12,500 shares to a Donor Advised Fund.
• Additionally, Guthart sold 3,720 shares held in trust for his daughter and 3,720 shares held in trust for his son, both at weighted average prices around $445.
• These transactions were conducted under a pre-arranged trading plan that complies with SEC Rule 10b5-1, set to expire on April 30, 2025.
• Following these transactions, Guthart directly owns 17,170 shares and indirectly owns 1,191,144 shares through a trust, 23,640 shares in trust for his daughter, and 23,640 shares in trust for his son.

Sentiment

Score: 6

Explanation: Neutral sentiment. The transactions appear to be part of a pre-planned strategy (10b5-1) and include both sales and charitable donations. The CEO exercising options is generally a positive sign, but the subsequent sales offset this.

Positives

• The transactions were conducted under a pre-arranged 10b5-1 trading plan, which can reassure investors that the sales were not based on insider information.

Risks

• Large sales by insiders, even under a 10b5-1 plan, can sometimes be perceived negatively by the market.

Future Outlook

The CEO's transactions will continue to be governed by the existing 10b5-1 trading plan until its expiration on April 30, 2025.

Industry Context

Executive stock transactions are common in publicly traded companies, and the use of 10b5-1 plans is a standard practice to avoid insider trading concerns. Monitoring these transactions provides insights into executive sentiment and potential future stock performance.

Comparison to Industry Standards

• Executive compensation packages in the medical device industry often include stock options and restricted stock units to align management's interests with those of shareholders.
• The use of 10b5-1 trading plans is a widespread practice among executives at publicly traded companies, including competitors like Medtronic and Stryker, to manage their personal finances while avoiding accusations of insider trading.
• Donating shares to Donor Advised Funds is a common tax-efficient strategy employed by high-net-worth individuals, including executives in the healthcare sector.

Stakeholder Impact

• The transactions could have a minor impact on shareholders due to the potential dilution from option exercises and selling pressure from share sales.
• The donation to a Donor Advised Fund has a positive social impact.

Key Dates